https://orcid.org/0000-0001-8962-6250
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tomiki Sumiyoshi, Hiroyuki Uchida, Koichiro Watanabe, Masato Oosawa, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 18, pages 2507-2517.
Read now
Read now
Gang Wang, Le Xiao, Hongye Ren, Kenneth Simonsen, Jingdong Ma, Xiangdong Xu, Ping Guo, Zhiren Wang, Ludong Bai, Elin Heldbo Reines & Lene Hammer-Helmich. (2022) Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study. Neuropsychiatric Disease and Treatment 18, pages 1939-1950.
Read now
Read now
Laura Santos, Fernanda Catelani, Sandra Mayworm, Herve Quinart, Christiano Bittencourt Machado & Redha Taïar. (2021) Effect of a wellness room with a physiotherapist in an intimate fashion company on ergonomics: stress level, quality of life and musculoskeletal symptoms. Theoretical Issues in Ergonomics Science 22:2, pages 125-138.
Read now
Read now
Articles from other publishers (7)
Susana S Almeida, Michael Cronquist Christensen, Kenneth Simonsen & Michael Adair. (2022) Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study. Journal of Psychopharmacology 37:3, pages 279-288.
Crossref
Crossref
Jia Zhou, Jingjing Zhou, Lei Feng, Yuan Feng, Le Xiao, Xu Chen, Jian Yang & Gang Wang. (2022) The associations between depressive symptoms, functional impairment, and quality of life, in patients with major depression: undirected and Bayesian network analyses. Psychological Medicine, pages 1-13.
Crossref
Crossref
N. N. Petrova. (2022) The effectiveness of vortioxetine in patients with depression in real clinical practice. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 56:3, pages 113-118.
Crossref
Crossref
Shinichi Noto, Mayumi Wake, Izumi Mishiro, Lene Hammer-Helmich, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy. Value in Health Regional Issues 30, pages 127-133.
Crossref
Crossref
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A. Katzman, Mircea Polosan, Kenneth Simonsen & Lene Hammer-Helmich. (2022) Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Yanhong Liu, Yongsheng Tong, Lvzhen Huang, Jingxu Chen, Shaoxiao Yan & Fude Yang. (2021) Factors related to retinal nerve fiber layer thickness in bipolar disorder patients and major depression patients. BMC Psychiatry 21:1.
Crossref
Crossref
O. S. Troyan. (2021) AGEADJUSTED NORMATIVE DATA AND DISCRIMINATIVE VALIDITY OF COGNITIVE TESTS IN THE UKRAINIAN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Modern medical technology:2, pages 4-14.
Crossref
Crossref